当前位置:首页 - 行情中心 - 苑东生物(688513) - 财务分析 - 现金流量表

苑东生物

(688513)

  

流通市值:75.75亿  总市值:75.75亿
流通股本:1.77亿   总股本:1.77亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金753,065,731.04393,132,334.511,424,877,392.911,099,079,014.31
  收到的税费返还14,955.7518,071.981,260,204.56903,364.02
  收到其他与经营活动有关的现金50,334,407.8917,111,959.2487,118,204.8959,931,204.47
  经营活动现金流入小计803,415,094.68410,262,365.731,513,255,802.361,159,913,582.8
  购买商品、接受劳务支付的现金127,241,348.0359,944,335.4253,854,280.7201,109,790.85
  支付给职工以及为职工支付的现金165,208,988.8297,715,221.5316,874,640.1248,916,233.01
  支付的各项税费96,879,571.4345,484,532.23156,130,319.55103,803,434.38
  支付其他与经营活动有关的现金246,688,925.34111,562,705.93521,455,357.79387,265,933.86
  经营活动现金流出小计636,018,833.62314,706,795.061,248,314,598.14941,095,392.1
  经营活动产生的现金流量净额167,396,261.0695,555,570.67264,941,204.22218,818,190.7
二、投资活动产生的现金流量:
  取得投资收益收到的现金376,353.46376,353.46--
  处置固定资产、无形资产和其他长期资产收回的现金净额21,30036,139.96408,226.011,452,140.55
  收到的其他与投资活动有关的现金738,195,598.02424,711,356.271,331,410,951.42625,174,486.68
  投资活动现金流入小计738,593,251.48425,123,849.691,331,819,177.43626,626,627.23
  购建固定资产、无形资产和其他长期资产支付的现金40,016,073.4517,065,958.6986,283,090.3257,026,332.9
  投资支付的现金6,000,0006,000,00019,680,00019,680,000
  支付其他与投资活动有关的现金1,311,831,334.01955,676,299.081,592,307,945.861,136,113,471.66
  投资活动现金流出小计1,357,847,407.46978,742,257.771,698,271,036.181,212,819,804.56
  投资活动产生的现金流量净额-619,254,155.98-553,618,408.08-366,451,858.75-586,193,177.33
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,582,026.7-9,536,983.689,536,983.68
  取得借款收到的现金10,000,000-55,000,00035,000,000
  收到其他与筹资活动有关的现金110,924,932.538,289,443.67140,973,498.73135,749,961.3
  筹资活动现金流入小计124,506,959.238,289,443.67205,510,482.41180,286,944.98
  偿还债务支付的现金57,200,00030,000,00073,666,666.6771,466,666.67
  分配股利、利润或偿付利息支付的现金85,982,918.87403,013.8876,787,844.9876,727,234.42
  支付其他与筹资活动有关的现金85,930,989.1544,156,772.3381,375,471.2269,699,657.39
  筹资活动现金流出小计229,113,908.0274,559,786.21231,829,982.87217,893,558.48
  筹资活动产生的现金流量净额-104,606,948.79-66,270,342.54-26,319,500.46-37,606,613.5
四、汇率变动对现金及现金等价物的影响-1,063,542.42-423,703.76-470,178.96-194,430.1
五、现金及现金等价物净增加额-557,528,386.13-524,756,883.71-128,300,333.95-405,176,030.23
  加:期初现金及现金等价物余额836,878,171.24836,878,171.24965,178,505.19965,178,505.19
  期末现金及现金等价物余额279,349,785.11312,121,287.53836,878,171.24560,002,474.96
补充资料:
  净利润112,103,602.37-273,573,868.43-
  资产减值准备452,665.06-4,372,647.11-
  固定资产和投资性房地产折旧45,743,012.27-85,764,580.82-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧45,743,012.27-85,764,580.82-
  无形资产摊销10,351,465.81-6,847,843.86-
  长期待摊费用摊销910,417.14-1,519,836.83-
  处置固定资产、无形资产和其他长期资产的损失-18,530.1--29,348.33-
  固定资产报废损失193,223-208,834.63-
  公允价值变动损失-10,768,453.67--17,128,662.34-
  财务费用1,368,616.25-2,513,008.66-
  投资损失-2,306,057.61--39,005,713.4-
  递延所得税433,757.46--9,462,087.7-
  其中:递延所得税资产减少2,359,510.92--9,415,057.41-
    递延所得税负债增加-1,925,753.46--47,030.29-
  存货的减少-18,702,902.23--38,709,027.19-
  经营性应收项目的减少17,089,449.7--23,857,960.11-
  经营性应付项目的增加15,729,352.34-6,961,462.61-
  其他-4,479,890-11,588,567.73-
  现金的期末余额279,349,785.11-836,878,171.24-
  减:现金的期初余额836,878,171.24-965,178,505.19-
  现金及现金等价物的净增加额-557,528,386.13--128,300,333.95-
公告日期2026-08-212026-04-222026-04-222025-10-28
审计意见(境内)标准无保留意见
TOP↑